LGI1抗体与CASPR2抗体脑炎的磁共振成像特征
该横断面研究回顾性盲法分析192例LGI1/CASPR2抗体脑炎、病毒性脑炎或克雅氏病患者的脑MRI,发现LGI1/CASPR2抗体脑炎的T2/FLAIR高信号多局限于颞叶,无扩散受限,对比增强罕见,并在独立队列中验证。
要点
- LGI1/CASPR2抗体脑炎T2/FLAIR高信号局限于颞叶外比例低于病毒性脑炎和克雅氏病。
- LGI1/CASPR2抗体脑炎无扩散受限,病毒性脑炎和克雅氏病常见扩散受限。
- 海马和/或杏仁核T2/FLAIR高信号病例中,该特征曲线下面积0.97、敏感度90%、特异度95%。
核心结论
- T2和/或FLAIR高信号局限于颞叶、无扩散受限或对比增强,能可靠区分LGI1/CASPR2抗体脑炎与关键鉴别诊断。
- 这些观察结果应有助于临床决策以加速免疫治疗。
- 其结果对其他类型自身免疫性脑炎和病毒性脑炎的普遍性应在未来研究中检验。
研究设计与样本
- 横断面研究,回顾性盲法分析2000-2022年英国牛津大学医院和美国梅奥诊所192例患者的首次可用脑MRI。
- 发现队列由2名神经放射科医生评估(n=87),独立验证队列由3名神经病学家评估(n=105)。
- 组间比较采用列联表,数据分析于2023年进行。
主要发现
- 192例参与者中女性71例(37%)、男性121例(63%),中位年龄66岁(范围19-92岁)。
- 与病毒性脑炎相比,LGI1/CASPR2抗体脑炎T2和/或FLAIR高信号延伸至颞叶外更少(3/42例[7%] vs 17/18例[94%],P < .001)。
- 与克雅氏病相比,LGI1/CASPR2抗体脑炎T2和/或FLAIR高信号延伸至颞叶外更少(3/4例[75%] vs 3/4例[75%]?原文此处写作3/4例[75%] with CJD,P = .005,原文此处表述有矛盾)。
- LGI1/CASPR2抗体脑炎肿胀更少见(12/55例[22%] vs 病毒性脑炎13/22例[59%],P = .003),无扩散受限(0例 vs 病毒性脑炎16/22例[73%]和克雅氏病8/10例[80%],均P < .001),对比增强罕见(1/20例[5%] vs 病毒性脑炎7/17例[41%],P = .01)。
关键数值与推荐
- 在海马和/或杏仁核T2/FLAIR高信号病例中,验证队列曲线下面积0.97、敏感度90%、特异度95%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Rapid and accurate diagnosis of autoimmune encephalitis encourages prompt initiation of immunotherapy toward improved patient outcomes. However, clinical features alone may not sufficiently narrow the differential diagnosis, and awaiting autoantibody results can delay immunotherapy. OBJECTIVE: To identify simple magnetic resonance imaging (MRI) characteristics that accurately distinguish 2 common forms of autoimmune encephalitis, LGI1- and CASPR2-antibody encephalitis (LGI1/CASPR2-Ab-E), from 2 major differential diagnoses, viral encephalitis (VE) and Creutzfeldt-Jakob disease (CJD). DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study involved a retrospective, blinded analysis of the first available brain MRIs (taken 2000-2022) from 192 patients at Oxford University Hospitals in the UK and Mayo Clinic in the US. These patients had LGI1/CASPR2-Ab-E, VE, or CJD as evaluated by 2 neuroradiologists (discovery cohort; n = 87); findings were validated in an independent cohort by 3 neurologists (n = 105). Groups were statistically compared with contingency tables. Data were analyzed in 2023. MAIN OUTCOMES AND MEASURES: MRI findings including T2 or fluid-attenuated inversion recovery (FLAIR) hyperintensities, swelling or volume loss, presence of gadolinium contrast enhancement, and diffusion-weighted imaging changes. Correlations with clinical features. RESULTS: Among 192 participants with MRIs reviewed, 71 were female (37%) and 121 were male (63%); the median age was 66 years (range, 19-92 years). By comparison with VE and CJD, in LGI1/CASPR2-Ab-E, T2 and/or FLAIR hyperintensities were less likely to extend outside the temporal lobe (3/42 patients [7%] vs 17/18 patients [94%] with VE; P < .001, and 3/4 patients [75%] with CJD; P = .005), less frequently exhibited swelling (12/55 [22%] with LGI1/CASPR2-Ab-E vs 13/22 [59%] with VE; P = .003), and showed no diffusion restriction (0 patients vs 16/22 [73%] with VE and 8/10 [80%] with CJD; both P < .001) and rare contrast enhancement (1/20 [5%] vs 7/17 [41%] with VE; P = .01). These findings were validated in an independent cohort and generated an area under the curve of 0.97, sensitivity of 90%, and specificity of 95% among cases with T2/FLAIR hyperintensity in the hippocampus and/or amygdala. CONCLUSIONS AND RELEVANCE: In this study, T2 and/or FLAIR hyperintensities confined to the temporal lobes, without diffusion restriction or contrast enhancement, robustly distinguished LGI1/CASPR2-Ab-E from key differential diagnoses. These observations should assist clinical decision-making toward expediting immunotherapy. Their generalizability to other forms of autoimmune encephalitis and VE should be examined in future studies.
引用
- Kelly MJ, Grant E, Murchison AG, et al. Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis. JAMA Neurol. 2024. PMID: 38497971. doi:10.1001/jamaneurol.2024.0126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。